User profiles for Boris A. Hadaschik
 | Boris HadaschikUniversity Hospital Essen, Dept. of Urology; University of Duisburg-Essen Verified email at uk-essen.de Cited by 22469 |
[HTML][HTML] MRI-targeted or standard biopsy for prostate-cancer diagnosis
…, PB Singh, W Venderink, BA Hadaschik… - … England Journal of …, 2018 - Mass Medical Soc
Background Multiparametric magnetic resonance imaging (MRI), with or without targeted
biopsy, is an alternative to standard transrectal ultrasonography–guided biopsy for prostate-…
biopsy, is an alternative to standard transrectal ultrasonography–guided biopsy for prostate-…
[HTML][HTML] Apalutamide treatment and metastasis-free survival in prostate cancer
…, S Chowdhury, S Oudard, BA Hadaschik… - … England Journal of …, 2018 - Mass Medical Soc
Background Apalutamide, a competitive inhibitor of the androgen receptor, is under development
for the treatment of prostate cancer. We evaluated the efficacy of apalutamide in men …
for the treatment of prostate cancer. We evaluated the efficacy of apalutamide in men …
[HTML][HTML] The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
…, M Eder, M Eisenhut, S Boxler, BA Hadaschik… - European journal of …, 2015 - Springer
Purpose Since the introduction of positron emission tomography (PET) imaging with 68 Ga-PSMA-HBED-CC
(= 68 Ga-DKFZ-PSMA-11), this method has been regarded as a significant …
(= 68 Ga-DKFZ-PSMA-11), this method has been regarded as a significant …
[HTML][HTML] Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
…, HG Linhart, T Holland-Letz, BA Hadaschik… - European journal of …, 2014 - Springer
Purpose Positron emission tomography (PET) with choline tracers has found widespread use
for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased in …
for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased in …
Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review
… Boris A. Hadaschik has received research funding from Medcom and UroMed and is a paid
consultant to Dendreon, Janssen, and Teva. He has also received funding for conference …
consultant to Dendreon, Janssen, and Teva. He has also received funding for conference …
[HTML][HTML] Apalutamide and overall survival in prostate cancer
…, F Saad, S Chowdhury, S Oudard, BA Hadaschik… - European urology, 2021 - Elsevier
Background The phase 3 SPARTAN study evaluated apalutamide versus placebo in
patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and prostate-specific …
patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and prostate-specific …
Multiparametric magnetic resonance imaging (MRI) and MRI–transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy …
Background Multiparametric magnetic resonance imaging (mpMRI) and MRI fusion targeted
biopsy (FTB) detect significant prostate cancer (sPCa) more accurately than conventional …
biopsy (FTB) detect significant prostate cancer (sPCa) more accurately than conventional …
The value of PSA density in combination with PI-RADS™ for the accuracy of prostate cancer prediction
Purpose : Multiparametric magnetic resonance imaging has an emerging role in prostate
cancer diagnostics. In addition, clinical information is a reliable predictor of significant prostate …
cancer diagnostics. In addition, clinical information is a reliable predictor of significant prostate …
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging …
…, M Hohenfellner, BA Hadaschik - The Journal of …, 2015 - auajournals.org
Purpose : Multiparametric magnetic resonance imaging and magnetic resonance imaging
targeted biopsy may improve the detection of clinically significant prostate cancer. However, …
targeted biopsy may improve the detection of clinically significant prostate cancer. However, …
A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion
BA Hadaschik, TH Kuru, C Tulea, P Rieker… - The Journal of …, 2011 - auajournals.org
Purpose : We developed an effective way to precisely diagnose prostate cancer using a
novel prostate biopsy system that integrates pre-interventional magnetic resonance imaging …
novel prostate biopsy system that integrates pre-interventional magnetic resonance imaging …